Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 1 h ago
Peer-reviewedCC BY 4.0Frontiers in Immunology

Phenotypic shift from active class IV lupus nephritis to lupus podocytopathy: a case report highlighting the treatment-altering role of repeat kidney biopsy

  1. 1Department of Nephrology, Longyan First Affiliated Hospital of Fujian Medical University

Abstract

Background: The underlying pathophysiological mechanisms of proteinuria relapse in lupus nephritis (LN) patients during immunological remission are complex, often involving non-immune complex-mediated podocyte injury.

Case presentation: We report a 21-year-old male with class IV LN and thrombotic microangiopathy (TMA). After multi-target induction and maintenance therapy, the patient achieved complete clinical remission. During subsequent follow-up, he developed progressive nephrotic-range proteinuria while maintaining serological remission (persistently negative autoantibodies and normal complement levels). Intensification of conventional immunosuppressants was ineffective. A repeat kidney biopsy revealed significant resolution of immune complex deposits but prominent focal segmental glomerulosclerosis (FSGS)-like changes with extensive podocyte foot process effacement. The regimen was adjusted to a podocyte-targeted therapy centered on tacrolimus, resulting in a rapid and sustained reduction in proteinuria.

Conclusion: This case suggests that in the clinico-serological dissociation phase of LN, repeat kidney biopsy is of significant clinical value for identifying pathological phenotypic shifts, avoiding excessive immunosuppression, and guiding precision medicine.

Related

  1. Bimekizumab for Darier disease: A case report highlighting dual IL-17A and IL-17F inhibition as a potential treatment.
    Weipeng Xie, Priya Agarwal, Medha Rao +1
    JAAD case reportsPeer-reviewedCC BYFull textGenetics & genomicsEurope PMC
  2. Multi-omics profiling identifies a putative Akkermansia–HK3–lactate immunometabolic link associated with JPZS treatment in lupus nephritis
    Ming Li, Lijun Pang, Yunfei Li +2
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyCrossrefPMC
  3. Variovorax paradoxus alleviates bicarbonate-induced Fe limitation in cotton by altering the root-associated microbiome
    M. Khan, B. Pant, A. H. Kabir
    bioRxivPreprintAll rights reservedFull textPlant biologybioRxiv
  4. Age-Related Patterns of Selected Protein-Altering Somatic Mutations and Overall Survival in Colorectal Cancer: A Retrospective Comparative Cohort Study
    Ege Rıza Karagür, Yasemin Adalı
    GenesPeer-reviewedCC BYFull textGenetics & genomicsEurope PMC
  5. The chemorepellent effect of metformin limits bacterial penetration into mammalian mucus by altering bacterial motility
    K. Simpson, A. Ranson, M. Vazquez Gomez +11
    bioRxivPreprintAll rights reservedFull textMicrobiologybioRxiv
BibTeX
@article{wang2026phenotypic,
  title = {{Phenotypic shift from active class IV lupus nephritis to lupus podocytopathy: a case report highlighting the treatment-altering role of repeat kidney biopsy}},
  author = {Zhifa Wang and Jinxiu Deng and Jinfeng Shen and Hui Jiang and Fuzhen Wang},
  journal = {Frontiers in Immunology},
  year = {2026},
  month = oct,
  doi = {10.3389/fimmu.2026.1941706},
  url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1941706/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Phenotypic shift from active class IV lupus nephritis to lupus podocytopathy: a case report highlighting the treatment-altering role of repeat kidney biopsy
AU  - Zhifa Wang
AU  - Jinxiu Deng
AU  - Jinfeng Shen
AU  - Hui Jiang
AU  - Fuzhen Wang
PY  - 2026
DA  - 2026/10/06
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.1941706
UR  - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1941706/full
AB  - Background: The underlying pathophysiological mechanisms of proteinuria relapse in lupus nephritis (LN) patients during immunological remission are complex, often involving non-immune complex-mediated podocyte injury.  Case presentation: We report a 21-year-old male with class IV LN and thrombotic microangiopathy (TMA). After multi-target induction and maintenance therapy, the patient achieved complete clinical remission. During subsequent follow-up, he developed progressive nephrotic-range proteinuria while maintaining serological remission (persistently negative autoantibodies and normal complement levels). Intensification of conventional immunosuppressants was ineffective. A repeat kidney biopsy revealed significant resolution of immune complex deposits but prominent focal segmental glomerulosclerosis (FSGS)-like changes with extensive podocyte foot process effacement. The regimen was adjusted to a podocyte-targeted therapy centered on tacrolimus, resulting in a rapid and sustained reduction in proteinuria.  Conclusion: This case suggests that in the clinico-serological dissociation phase of LN, repeat kidney biopsy is of significant clinical value for identifying pathological phenotypic shifts, avoiding excessive immunosuppression, and guiding precision medicine.
SN  - 1664-3224
ER  -